Down-Regulation of TGF- β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib.

CONCLUSION: Our study provides a new therapeutic strategy for HCC that overcomes the resistance of HCC to sorafenib by down-regulation of TGF-β.
PMID: 28792132 [PubMed - in process]

Source: Yonsei Medical Journal - August 10, 2017 Category: Universities & Medical Training Authors: Kang D, Han Z, Oh GH, Joo Y, Choi HJ, Song JJ Tags: Yonsei Med J Source Type: research